Showing results (61-70 of 186) with videos related to

Sort By:
Pageof 19
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 21, 2008
Orexin signaling mediates the antidepressant-like effect of calorie restrictionMichael Lutter, Vaishnav Krishnan, Scott J Russo, et al.
Archives of Medical Science : AMS|October 3, 2014
Can echocardiographically estimated pulmonary arterial elastance be a non-invasive predictor of pulmonary vascular resistance?Neeraj Sinha, Srikala Devabhaktuni, Aparna Kadambi, et al.
Archives of Biochemistry and Biophysics|November 29, 2020
The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLDAriel Sasson, Eva Kristoferson, Rogerio Batista, et al.
Pharmacology & Therapeutics|September 9, 2021
Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implicationsJohn A McClung, Lior Levy, Victor Garcia, et al.
The American Journal of Cardiology|June 15, 2004
Comparison of frequency of left ventricular thrombi in patients with anterior wall versus non-anterior wall acute myocardial infarction treated with antithrombotic and antiplatelet therapy with or without coronary revascularizationDevraj Nayak, Wilbert S Aronow, Rishi Sukhija, et al.
Brain Research. Molecular Brain Research|December 8, 2004
DeltaFosB: a molecular switch for long-term adaptation in the brainColleen A McClung, Paula G Ulery, Linda I Perrotti, et al.
The American Journal of Case Reports|April 10, 2013
Giant myxoma causing heart failure symptomsAmit Chhabra, John A McClung, Srirama Kalapatapu, et al.
Heart Disease (Hagerstown, Md.)|April 27, 2002
Long-term clinical outcome of rescue balloon angioplasty compared with rescue stenting after failed thrombolysisS Koneru, C E Monsen, A Pucillo, et al.
Biomaterials|June 11, 2026
Impact of ClockΔ19 mutation on neural recording performance and neural inflammatory responsesVaishnavi Dhawan, Sharada Narayanan, Cort Thompson, et al.
American Journal of Therapeutics|December 31, 2008
Incidence of new stroke or new myocardial infarction or death at 39-month follow up in patients with diabetes mellitus, hypertension, or both treated with and without angiotensin-converting enzyme inhibitors or angiotensin receptor blockersGautham Ravipati, Wilbert S Aronow, Chul Ahn, et al.
Pageof 19